Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein c for ischemic stroke

Patricia D. Williams, Berislav V. Zlokovic, John H. Griffin, Kent E. Pryor, Thomas P. Davis

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 'Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein c for ischemic stroke'. Together they form a unique fingerprint.

Medicine & Life Sciences